Pulmonx Corp
General ticker "LUNG" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $249.1M
Pulmonx Corp does not follow the US Stock Market performance with the rate: -26.1%.
Estimated limits based on current volatility of 2.7%: low 5.94$, high 6.27$
Factors to consider:
- US accounted for 66.9% of revenue in the fiscal year ended 2023-12-31
- Current price 22.1% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [8.04$, 17.67$]
- 2024-12-30 to 2025-12-30 estimated range: [8.15$, 17.49$]
Financial Metrics affecting the LUNG estimates:
- Negative: Non-GAAP EPS, $ of -1.60 <= 0.10
- Negative: Operating profit margin, % of -47.42 <= 1.03
- Negative: Operating cash flow per share per price, % of -7.69 <= 2.35
- Positive: Industry inventory ratio change (median), % of 0.19 <= 0.49
- Negative: Industry operating profit margin (median), % of -26.46 <= 2.14
- Positive: Interest expense per share, $ of 0.09 <= 0.14
Short-term LUNG quotes
Long-term LUNG plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $48.42MM | $53.66MM | $68.67MM |
Operating Expenses | $95.72MM | $112.30MM | $130.61MM |
Operating Income | $-47.30MM | $-58.64MM | $-61.94MM |
Non-Operating Income | $-1.01MM | $0.07MM | $1.66MM |
Interest Expense | $0.83MM | $1.07MM | $3.23MM |
R&D Expense | $13.06MM | $15.40MM | $18.08MM |
Income(Loss) | $-48.32MM | $-58.57MM | $-60.27MM |
Taxes | $0.34MM | $0.35MM | $0.57MM |
Profit(Loss) | $-48.66MM | $-58.92MM | $-60.84MM |
Stockholders Equity | $193.24MM | $154.01MM | $118.31MM |
Inventory | $16.29MM | $14.56MM | $16.74MM |
Assets | $235.17MM | $193.68MM | $177.78MM |
Operating Cash Flow | $-41.39MM | $-45.08MM | $-37.61MM |
Capital expenditure | $3.67MM | $1.32MM | $0.81MM |
Investing Cash Flow | $-46.26MM | $-4.22MM | $-2.01MM |
Financing Cash Flow | $4.46MM | $2.47MM | $21.40MM |
Earnings Per Share* | $-1.35 | $-1.59 | $-1.60 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.